EP-1260: Risk factors for acute toxicity in prostate cancer patients receiving hypofractionated IMRT. (April 2015) - Matrone, F.; Montesi, G.; Saldi, S.; Bellavita, R.; Frattegiani, A.; Lupattelli, M.; Zucchetti, C.; Cusco, S.; Bini, V.; Aristei, C.